Myocardial outflow of calcitonin gene-related peptide in relation to metabolic stress during coronary artery bypass grafting without cardiopulmonary bypass  by Källner, Göran et al.
CPB has recently gained increased attention.3 The short-
term to midterm clinical outcome in these operations in
terms of morbidity and mortality has been character-
ized,4,5 and the results are encouraging. In these opera-
tions, coronary flow in the vessel being bypassed has to
be interrupted, usually for 10 to 20 minutes, while the
distal anastomosis is constructed. The myocardial meta-
bolic stress that results from this intraoperative tempo-
rary interruption of coronary blood flow has not been
thoroughly investigated in human beings. In experimen-
tal ischemia in the pig, a 300% increase in tissue lactate
was observed within 15 minutes,6 and lactate production
is widely used as an indicator of anaerobic metabolism.7
In clinical situations such as conventional CABG,8
unstable angina,9 and radiofrequency catheter ablation,10
troponin T has proved to be a highly sensitive and spe-
cific tool in evaluating even minor myocardial damage,
C oronary artery bypass grafting (CABG) is routinelyperformed with cardiopulmonary bypass (CPB),
with excellent results. However, CPB has been associat-
ed with several adverse effects,1,2 and CABG without
Objective: Because of adverse effects of cardiopulmonary bypass and the
prospect of shortening intensive care and hospital stay, coronary artery
bypass grafting without cardiopulmonary bypass is gaining increased
attention. The impact of the localized myocardial ischemia that is inher-
ent in these procedures has not been thoroughly investigated in human
beings. We have investigated metabolic changes, possible myocardial
damage, and myocardial outflow of the vasodilator calcitonin gene-
related peptide during coronary artery bypass grafting without car-
diopulmonary bypass. Methods: Coronary sinus and arterial blood was
sampled before coronary arterial occlusion, after 10 minutes of
ischemia, and after 1 and 10 minutes of reperfusion in 9 consecutive
patients (mean age 70 ± 5 years) who had an anastomosis performed to
the left anterior descending artery without cardiopulmonary bypass.
Results: No perioperative myocardial infarctions occurred. The arterio-
venous difference in lactate decreased during ischemia, to reach a min-
imum after 1 minute of reperfusion (–0.17 ± 0.25 vs 0.15 ± 0.25 mmol/L
before ischemia; P = .008). Myocardial lactate extraction decreased
(from 11.2 ± 13.6 m mol/min before ischemia to –3.0 ± 7.0 m mol/min after
1 minute of reperfusion; P = .012), that is, a net production of lactate.
The arteriovenous difference in calcitonin gene-related peptide
decreased from –0.1 ± 2.6 pmol/L before ischemia to –30.5 ± 26.5 pmol/L
(P = .008) after 1 minute of reperfusion. Conclusions: The localized
myocardial ischemia associated with these procedures causes metabolic
changes in the myocardium, but no myocardial damage. The ischemia-
related outflow of calcitonin gene-related peptide indicates that the
vasodilating and cardioprotective properties of this peptide that are
known from animal studies may be of importance in myocardial
ischemia in human beings. (J Thorac Cardiovasc Surg 1999;117:447-53)
Göran Källner, MDa
Anders Öwall, MD, PhDb
Anders Franco-Cereceda, MD, PhDa
From the Departments of Thoracic Surgerya and Cardiothoracic
Anesthesia,b Karolinska Hospital, Stockholm, Sweden.
Supported by grants from the Wallenberg Foundation, the Swedish
Heart-Lung Foundation, the Swedish Medical Research Council,
and funds from the Karolinska Institute.
Received for publication June 1, 1998; revisions requested Aug 19,
1998; revisions received Sept 8, 1998; accepted for publication
Oct 7, 1998.
Address for reprints: Göran Källner, MD, Department of
Cardiothoracic Surgery and Anesthesiology, Karolinska Institute
at Huddinge University Hospital, S-141 86 Huddinge, Sweden.
Copyright © 1999 by Mosby, Inc.
0022-5223/99 $8.00 + 0 12/1/95022
447
MYOCARDIAL OUTFLOW OF CALCITONIN GENE-RELATED PEPTIDE IN RELATION TO METABOLIC
STRESS DURING CORONARY ARTERY BYPASS GRAFTING WITHOUT CARDIOPULMONARY BYPASS
but information on release of troponin T in CABG per-
formed without CPB is scarce.11
In myocardial ischemia, slow-conducting C-fiber
afferents are activated.12,13 This activation is associated
with release of calcitonin gene-related peptide (CGRP),
which has potent chronotropic and vasodilator
effects.13 In experimental models of myocardial
ischemia, C-fiber activation with CGRP release causes
improvement of postischemic cardiac function.14
Furthermore, in patients with acute myocardial infarc-
tion, an almost 2-fold increase in plasma CGRP within
24 hours of hospital admittance has been observed.15
CABG without CPB represents a unique opportunity to
study the effects of a well-defined and controlled
ischemic episode in human beings in vivo. The aim of
the present study was to evaluate myocardial metabol-
ic disturbance and possible myocardial damage during
CABG without CPB and to investigate to what extent
such disturbance is associated with activation of car-
diac C-fibers and outflow of C-fiber peptides.
Patients and methods
Patients. This study was approved by the Karolinska
Hospital Human Research Committee. Patients requiring
grafts in the left anterior descending coronary artery (LAD)
system only or in the LAD system and right coronary artery
system were offered surgery without CPB. Our present poli-
cy is to use CPB to perform circumflex grafts. Further exclu-
sion criteria for surgery without CPB were significant left
main stenosis and severely depressed left ventricular func-
tion. All patients who underwent elective coronary surgery
without CPB from January 1998 through April 1998 were eli-
gible for the study and were included after informed consent.
Our study group consisted of 7 men and 2 women. All
patients but 2 had had 1 or more myocardial infarctions.
Three patients had an occluded LAD; the remaining 6
patients had significant LAD stenosis. Left ventricular func-
tion was classified as normal, mildly depressed, or moderately
depressed as assessed from angiography or perioperative
transesophageal echocardiography, or both studies. The pre-
operative and intraoperative data are shown in Table I.
Anesthetic and surgical technique. Intramuscular premed-
ication with morphine and scopolamine was given 1 hour
before anesthesia. Anesthesia was induced with thiopental,
midazolam, and fentanyl and was maintained with a continu-
ous infusion of midazolam and fentanyl. Pancuronium was
given before endotracheal intubation, followed by normocap-
nic, volume-controlled ventilation with 50% oxygen in air.
Heparin (1 mg/kg) was given before distal division of the left
internal thoracic artery (LITA). The radial artery was cannu-
lated for continuous blood pressure recording and blood sam-
pling. The 5-lead electrocardiogram (ECG) with automatic
analysis of the ST segment was continuously monitored, and
all patients were monitored with transesophageal echocardio-
graphy. Esmolol was given as requested by the surgeon, start-
ing with a loading dose of 0.5 mg/kg and then as an infusion
at 50 to 300 m g/kg per minute.
The operation was performed through a midline sternoto-
my or through a left anterior small thoracotomy, according to
the surgeon’s preference. The LITA was harvested for anas-
tomosis to the LAD. Additional grafts were performed with
the saphenous vein or the left radial artery. When multiple
vessels were bypassed, the anastomosis to the LAD was con-
structed first, except in 1 patient in whom a diagonal branch
was anastomosed before the LAD for anatomic reasons. In
this patient the preischemic samples were drawn before diag-
onal branch ischemia. A 2-0 Prolene suture (Ethicon, Inc,
Somerville, NJ) was passed around the LAD just proximal
and just distal to the anastomotic site. The snares were tight-
ened for 2 to 3 minutes for ischemic preconditioning and to
test the tolerability of the ischemia (patients 3-9). After 4 to 5
minutes of reperfusion the snares were tightened again to
ensure an operative field as bloodless as possible. The anas-
tomotic site was stabilized with an Origin OMS-CS cardiac
stabilizer (Origin USA, Menlo Park, Calif). The anastomosis
was then constructed with a continuous 8-0 Prolene suture.
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Table I. Preoperative and intraoperative data
LAD Pre-
Patient Age Previous LV LAD Grafted ischemia conditioning 
No. Sex (y) MI function occluded vessels (min) (min) Incision
1 M 73 No MI Mild No LAD + diag 19 0 Sternotomy
2 M 68 A + I Mild Yes LAD 16 0 LAST + sternotomy
3 F 75 A Normal No LAD + diag 14 3 Sternotomy
4 M 58 A Moderate Yes LAD 9 2 Sternotomy
5 M 77 A + I Mild Yes LAD + RCA 22 3 Sternotomy
6 M 73 A Normal No LAD 17 3 LAST
7 M 73 A Mild No LAD + diag 13 2 Sternotomy
8 M 65 A Mild No LAD + RCA 19 2 Sternotomy
9 F 71 No MI Normal No LAD + diag + RCA 16 3 Sternotomy
MI, Myocardial infarction (A, anterior; I, inferior); LV, left ventricular (mild, mildly depressed function; moderate, moderately depressed function); LAD, left anteri-
or descending coronary artery; diag, diagonal branch; RCA, right coronary artery; LAST, left anterior small thoracotomy.
After completion of the LITA-LAD anastomosis, the snares
and the occluder on the LITA were released. Additional anas-
tomoses were not started before at least 10 minutes had
elapsed after re-establishment of LAD flow. Intraoperative
data are shown in Table I.
Study protocol. A thermodilution catheter (Webster Lab-
oratories, Altadena, Calif) was inserted into the coronary
sinus through the right internal jugular vein under fluoro-
scopic guidance.16 The catheter was advanced to the proximal
part of the great cardiac vein. The correct position in the coro-
nary sinus was verified by analysis of the blood oxygen satu-
ration. Coronary sinus blood flow was measured in duplicate
by the retrograde thermodilution technique, with the use of
saline solution.17 This catheter was used for coronary sinus
blood sampling and flow measurements at the following
times: after opening of the pericardium but before LAD
ischemia, at 10 minutes of LAD ischemia, 1 minute after re-
establishment of LAD flow, and 10 minutes after re-estab-
lishment of LAD flow. Simultaneous samples were drawn
from the radial artery. Each sample was immediately ana-
lyzed for total oxygen content with the use of an OSM 3
Hemoximeter connected to an ABL 505 blood gas analyzer
(Radiometer A/S, Copenhagen, Denmark). The samples were
collected in vacuum tubes (containing sodium fluoride for the
lactate analysis, ethylenediaminetetraacetic acid for analysis
of CGRP, and gel barrier without anticoagulation for the
analysis of troponin T), kept in ice slush, and centrifuged (10
minutes, 4°C) at 1620g within 30 minutes of collection of the
last sample. The plasma was then immediately frozen at
–70°C and stored until analysis. Heart rate, mean arterial
pressure, and ST-segment deviation were recorded at each
sampling point with a Tram 600 SL module, connected to a
Tramscope 12C (Marquette Electronics Inc., Milwaukee, Wis).
On postoperative day 1, a 12-lead ECG was recorded, and
peripheral venous blood samples were drawn for routine
analysis of creatine kinase, aspartate aminotransferase, and
alanine aminotransferase concentrations. Our ECG criteria
for transmural myocardial infarction were new Q waves of
more than 0.03 second in duration in at least 2 anatomically
adjacent leads. A localized ST-segment elevation followed by
T-wave inversion in at least 2 adjacent leads was considered
diagnostic of acute subendocardial myocardial infarction. In
the absence of ECG changes, a non–Q wave infarction was
diagnosed by means of the following enzymatic criteria (units
per liter): aspartate aminotransferase more than 180 (with
alanine aminotransferase <60 and creatine kinase >1200).
The upper reference limits in our laboratory are 48 U/L for
aspartate aminotransferase and alanine aminotransferase and
1200 U/L for creatine kinase. 
Lactate in plasma was determined with the use of a ”dry
chemistry” kit from Vitros (Johnson & Johnson, New York,
NY) and analyzed spectrophotometrically in a Vitros 950 ana-
lyzer. The range of the analysis is 0.50 to 12.00 mmol/L, and
the reference interval is 0.7 to 2.1 mmol/L. Cardiac troponin
T in serum was determined with the second-generation tro-
ponin T enzyme-linked immunosorbent assay (Enzymun-Test
Troponin-T) on the ES 300 system (Boehringer Mannheim
GmbH, Mannheim, Germany). The lower detection limit is
0.01 m g/L, the cutoff value for myocardial damage is 0.1 m g/L,
and the cross-reactivity with skeletal muscle troponin T is less
than 0.01%.18 CGRP was analyzed with radioimmunoassay
with the use of antibody raised against human CGRP-a
(Peninsula Laboratories Inc, Belmont, Calif).19
Calculations and statistical evaluation. For oxygen, lac-
tate, and CGRP, the concentration in coronary venous plasma
was subtracted from the concentration in arterial plasma to
form the arteriovenous concentration difference. The myocar-
dial extraction (or outflow) of substances was calculated by
multiplying the arteriovenous concentration difference by the
flow in the coronary sinus, corrected for hematocrit value.
These parameters and mean arterial pressure, heart rate, and
coronary sinus blood flow were then evaluated by the
Friedman analysis of variance by ranks test,20 using STATIS-
TICA software, version 5.1 (StatSoft Inc, Tulsa, Okla). If this
indicated significance at the .05 level, a Wilcoxon matched
pairs test between the peak values and the preischemic values
was done. Values are expressed as mean ± SD.
Results
Clinical outcome. The in-hospital mortality was
zero, and all patients were discharged from the hospital
within 6 to 8 days. No perioperative myocardial infarc-
tions occurred. In patient 2, a conversion from left ante-
rior small thoracotomy to sternotomy was done be-
cause of technical difficulties with the LITA.
Signs of ischemia and metabolic adjustment.
Mean arterial pressures before ischemia, at 10 minutes
of ischemia, and after 10 minutes of reperfusion were
71 ± 11, 67 ± 6, and 65 ± 13 mm Hg, respectively. This
slight decrease in blood pressure was not significant (P
= .32). Likewise, heart rate did not change significant-
ly over time (70 ± 13, 71 ± 27, and 67 ± 20 beats/min,
respectively; P = .067). The automatic analysis of the
ST segment showed no signs of ischemia in any of the
patients; any aberrations were within 0.1 mV.
The preischemic blood flow measured in the coro-
nary sinus was 64 ± 53 mL/min. There was a trend
toward elevated flow at 1 and 10 minutes of reperfusion
(Fig 1). Before myocardial ischemia the arterial and
coronary sinus lactate levels were 1.11 ± 0.35 and 0.96
± 0.26 mmol/L, respectively. Although the arterial lac-
tate level did not change significantly (P = .47) during
or after ischemia, a significant increase in coronary
sinus lactate was noted at 1 minute of reperfusion (1.25
± 0.25 mmol/L, P = .015). The arteriovenous difference
in lactate concentration decreased during ischemia to
reach a minimum after 1 minute of reperfusion (–0.17
± 0.25 vs 0.15 ± 0.25 mmol/L before ischemia; P =
.008). Myocardial lactate extraction also decreased
(from 11.2 ± 13.6 m mol/min before ischemia to –3.0 ±
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7.0 m mol/min after 1 minute of reperfusion; P = .012)
(Fig 2), that is, a net production of lactate. The arterio-
venous oxygen concentration difference tended to be
lower at 1 minute of reperfusion compared with the
preischemic level (82 ± 13.0 vs 95 ± 20 mL/L), where-
as the myocardial oxygen extraction was elevated (7.2
± 5.2 vs 6.1 ± 5.3 mL/min) (Fig 3). These changes were
not significant (P = .17 and P = .58, respectively).
Patient 3 had a slight elevation in coronary sinus tro-
ponin T level (0.35 m g/L) in the preischemic sample.
All other troponin T samples were within the normal
range.
Outflow of CGRP. The preischemic arterial and coro-
nary sinus plasma levels of CGRP were 5.1 ± 3.5 and 5.1
± 3.9 pmol/L, respectively. The arterial level of CGRP
showed a minimal variation (P = .20) during ischemia
and reperfusion, whereas at 1 minute of reperfusion there
was a marked increase in CGRP in the coronary sinus
(34.9 ± 25.7 vs 5.1 ± 3.9 pmol/L before ischemia; P =
.008), paralleled by a corresponding decrease in arterio-
venous difference in CGRP level (from –0.1 ± 2.6
pmol/L before ischemia to –30.5 ± 26.5 pmol/L after 1
minute of reperfusion; P = .008) (Fig 4). Myocardial out-
flow of CGRP increased (from 0.08 ± 0.27 pmol/min
before ischemia to 1.84 ± 2.34 pmol/min after 1 minute
of reperfusion; P = .012) (Fig 4).
Discussion
This study shows that the relatively short-lasting and
limited ischemia that is associated with CABG without
CPB induces adjustments in lactate metabolism.
Furthermore, outflow of CGRP increased immediately
on reperfusion of the ischemic myocardium, indicating
C-fiber activation. There were, however, no hemody-
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Fig 1. Coronary sinus blood flow. isch, Ischemia; rep, reperfusion.
Fig 2. Arterial and coronary sinus lactate levels and arteriovenous difference in lactate level (AV diff) on the left
Y-axis, and myocardial lactate extraction on the right Y-axis. *P < .05. **P < .01 for lactate levels and AV diff
versus preischemic values. ++P < .01 for lactate extraction versus preischemic values.
namic or ECG changes during the operative procedure.
The heart normally extracts lactate as a part of aerobic
metabolism.21 Although myocardial lactate production
is considered to be a good indicator of myocardial
ischemia,7 it should be kept in mind that coronary sinus
lactate levels only vaguely reflect the substantially ele-
vated lactate levels in ischemic tissue.6 Thus the pre-
sent finding of myocardial lactate production during
and early after ischemia most likely represents true
myocardial ischemia. In this context, ST-segment
changes in the ECG are of very limited value, particu-
larly because of low sensitivity.7 The absence of ST-
segment changes in the present study thus has little
bearing on the assessment of ischemia.
Under basal conditions, the heart extracts a high and
relatively fixed percentage of the oxygen from the
coronary arterial blood. Therefore the oxygen debt that
results from an ischemic episode must be met mainly
by an increased myocardial perfusion. In our study the
myocardial arteriovenous oxygen concentration differ-
ence actually decreased during early reperfusion, while
oxygen consumption increased. Although none of
these changes were statistically significant, it might be
assumed that in the course of the postischemic hyper-
emia (caused by metabolic, humoral, and neuronal
mediators) some shunting of blood occurs in, and adja-
cent to, the previously ischemic myocardium.
The study group shows considerable heterogeneity in
some important respects. Seven patients had had a pre-
vious anterior myocardial infarction, and 3 patients had
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 3
Källner, Öwall, Franco-Cereceda   451
Fig 3. Total arterial and coronary sinus oxygen concentration (CaO2 and CvO2, respectively), and arteriovenous
oxygen difference (AV O2 diff) on the left Y-axis, and oxygen consumption (VO2) on the right Y-axis.
Fig 4. Arterial and coronary sinus CGRP levels and arteriovenous difference in CGRP level (AV diff) on the left
Y-axis and CGRP extraction on the right Y-axis. **P < .01 for CGRP levels and AV diff versus preischemic val-
ues. ++P < .01 for CGRP extraction versus preischemic values.
an occluded LAD. Thus the amount of viable myocardi-
um exposed to ischemia during the procedure probably
differed considerably among the patients. A larger pro-
portion of patients with an open, stenosed LAD and a
noninfarcted anterior wall would probably have yielded
more obvious results in the studied parameters, includ-
ing coronary sinus flow and oxygen consumption.
In accord with Hadjinikolaou and associates,11 we
did not detect any elevation of troponin T concentration
in peripheral blood in patients undergoing CABG with-
out CPB. The elevated troponin T level in the coronary
sinus in 1 patient indicates cardiac release. However,
since the elevation was present before the perioperative
ischemia, this finding cannot be attributed to the LAD
occlusion, but possibly to some minor ischemic episode
in the preoperative period.
Cardiac C-fiber afferents are characterized by a rapid
increase in firing rate on occlusion of a coronary artery.22
A proportion of these C-fibers contain CGRP, which is
released by cardiac ischemia in vitro.19 Thus increased
outflow of CGRP has been shown in the guinea pig heart
after 5 minutes of ischemia.19 Furthermore, CGRP is
released in the heart after activation of C-fiber afferents
by lactic acid and low pH perfusion,23 that is, conditions
that correspond well with the metabolic disturbances
associated with ischemia. CGRP has a cardioprotective
effect in postischemic rat hearts, whereas the CGRP-
receptor antagonist CGRP(8-37) impairs postischemic
cardiac function.14 In the pig, in vivo local administra-
tion of CGRP augmented myocardial hyperemia after 45
minutes of LAD occlusion.24
In previous studies in human beings, elevated levels
of CGRP were found in peripheral blood in patients
with acute myocardial infarction,15 but it could not be
proved whether this represented myocardial release.
The patients in the present study can be assumed to
have some degree of collateral flow to the anterior wall,
as opposed to patients who have an acute coronary arte-
rial occlusion. The possible role for CGRP in such
patients may be restricted to the ischemic border zone.
The myocardial outflow of CGRP that is shown in this
study implies that CGRP-mediated mechanisms of
local vasodilation and myocardial protection found in
animal studies may also be operative in myocardial
ischemia in human beings.
The technical assistance by Gunilla Barr, CRNA, is grate-
fully acknowledged.
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